ReviewDermatology and therapy2026
Actinic Keratosis at the Crossroads of Inflammation and Cutaneous Dysbiosis.
Review in Dermatology and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Malondialdehyde and Oxidative Stress in Cancer: Biological Insights and Clinical Perspectives.Biomedicines · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Actinic keratosis (AK) represents an early stage of keratinocyte carcinogenesis and has long been attributed primarily to cumulative ultraviolet (UV) radiation-induced genetic damage. However, increasing evidence suggests that AK arises within a complex cutaneous microenvironment, in which chronic inflammation, oxidative stress, immune dysregulation, and alterations of the skin microbiota interact to promote and sustain field cancerization. UV exposure not only drives mutational events in epidermal keratinocytes, but also disrupts barrier integrity and local immune surveillance, reshaping microbial community structure on photodamaged skin. Recent studies reveal a characteristic profile in AK, characterized by reduced microbial diversity, depletion of protective commensals, and enrichment of opportunistic taxa, most notably Staphylococcus aureus. Experimental and clinical data suggest that S. aureus may act as a microbial cofactor in AK by amplifying proinflammatory and pro-oxidant signaling, inducing genotoxic stress, impairing DNA repair pathways, and modulating local immune responses in a manner consistent with early carcinogenic progression. Concurrent loss of commensal bacteria and fungi with immunomodulatory functions may further destabilize epidermal homeostasis, potentially reinforcing a self-perpetuating inflammatory loop. This perspective review synthesizes current molecular, immunologic, and microbial evidence to elucidate the role of host-microbe interactions in AK arising on chronically UV-exposed skin. Finally, we discuss how targeting inflammation-microbiota crosstalk may open new opportunities for risk stratification, prevention, and therapeutic intervention across the AK-cutaneous squamous cell carcinoma spectrum.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.